Visual Evoked Potential (VEP) Testing
Customize your policy alerts
Sign up for chocchildrenshospitalorangecountyhealthalliance Policy 4.0 alerts
Get alerted when Policy 4.0 changes without checking for updates manually.
Monitor payer policy activity
Defines medical necessity, documentation, and coverage criteria for Visual Evoked Potential (VEP) testing (CPT 95930) for members of the health plan; applies to providers requesting coverage under the plan.
No material clinical or coverage changes in this revision.
Coverage Criteria for Visual Evoked Potential (VEP) Testing
Covered Indications / Medical Necessity for CPT 95930
Covered when ANY of the following indication groups are present and documentation requirements are met:
VEP testing is considered medically necessary for this indication; annual testing allowed.
VEP testing is considered medically necessary for this indication; annual testing allowed.
Documentation Requirements to Establish Medical Necessity
All of the following must be clearly and legibly documented in the medical record and available upon request:
Areas where 'white out' is used are not accepted; areas with 'black out' or 'scribble' are not accepted; a single-line correction is acceptable if initialed and dated by the provider. Physician signature must be present on chart, procedural notes, orders, and testing interpretations.
This policy explicitly states that there are no exclusions. All applicable indications and documentation requirements described elsewhere in the policy apply; no specific patient populations, diagnoses, or service settings are excluded by the policy language.
Coding — CPT and ICD-10
| 95930 | Visual evoked potential (VEP) testing |
| A39.82 | Meningococcal retrobulbar neuritis |
| C70.0-C70.9 | Malignant neoplasm of cerebral meninges |
| C72.0-C72.9 | Malignant neoplasm of spinal cord/central nervous system |
| C79.31-C79.32 | Secondary malignant neoplasm of brain/cerebral meninges |
| C79.49 | Secondary malignant neoplasm of other parts of nervous system |
| D32.0-D32.9 | Benign neoplasm of cerebral meninges |
| D33.2-D33.7 | Benign neoplasm of brain/other parts of central nervous system |
| D42.0-D42.9 | Neoplasm of uncertain behavior of cerebral meninges |
| D43.2-D43.4 | Neoplasm of uncertain behavior of brain/spinal cord |
| D44.4-D44.5 | Neoplasm of uncertain behavior of craniopharyngeal duct/pineal gland |
Provider Actions, Prior Authorization, and Documentation
Prior authorization required for CPT 95930 (VEP)
Prior authorization is required for CPT 95930 and will be approved only when submitted documentation establishes medical necessity per the policy and includes the required medical record elements.
- Submit prior authorization for CPT code 95930 before performing VEP testing.
- Include all documentation elements listed under Medical Necessity Requirements (dates, findings, diagnosis, physician signature, copies of tests, etc.).
Provider responsibilities for VEP authorization and documentation
No additional summary label was provided in the source for this provider-facing callout; follow the policy requirements for prior authorization, documentation, and medical necessity when submitting requests for VEP testing.
- Refer to Sections II and III of the policy for covered indications and medical necessity documentation requirements.
- Ensure submissions correspond to the ICD-10 diagnoses listed in Table 1 to support medical necessity.
Documentation must include all required elements and physician signature
Medical records must clearly and legibly document all criterion points and the information listed in Table 1; physician signature is required on the chart, procedural notes, orders, and testing interpretations.
- Document date of test and date of interpretation.
- Record findings, progression/stable notation (unless baseline), and diagnosis.
- Maintain copies of tests and computer analysis for future comparison; avoid white‑out or blacked/scribbled areas; single-line corrections acceptable if initialed and dated.
Denial risk for incomplete or insufficient documentation
Services will be denied for prior authorization requests when submitted documentation does not establish medical necessity, is incomplete, or the provider fails to respond to requests for additional information; repeated failures may be referred to Quality and adverse determinations will include appeal rights.
- Ensure submitted records justify the diagnosis and reasons the procedure was necessary for planning therapy and monitoring disease.
- Respond promptly to requests for clarifying information to avoid denial.
Background
Visual Evoked Potentials (VEPs) are electrophysiologic responses elicited by patterned or unpatterned visual stimuli and recorded to evaluate the function of the visual pathways. VEP testing is used clinically to assist in diagnosis and monitoring of optic nerve and visual pathway disorders, and is referenced in this policy as the procedure governed by CPT 95930.
Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.